Form 4: Veracyte VP Jonathan Wygant Reports Stock Transactions

Veracyte's VP, Chief Accounting Officer Jonathan Wygant, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Summary

• On September 2, 2024, Jonathan Wygant, VP, Chief Accounting Officer of Veracyte, Inc., reported a transaction involving common stock.
• The transaction involved the withholding of 1,087 shares of common stock to satisfy tax obligations related to the vesting of restricted stock units.
• These restricted stock units were granted on February 22, 2022 (750 units), August 5, 2022 (713 units), and March 6, 2023 (678 units).
• The price per share for the transaction was $31.55.
• Following the transaction, Wygant beneficially owns 47,345 shares of Veracyte common stock, which includes 461 shares purchased through the Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions related to executive compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding insider transactions but doesn't necessarily reflect broader industry trends.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it primarily concerns the executive's tax obligations and stock ownership.

Key Dates